Injections of α-MSH peptide or DNA plasmids encoding for α-MSH have been used as experimental therapy to suppress graft rejection, inflammation, and autoimmune diseases in the eye and in the CNS [22–28]. This evidence concerns the gene STAMBP and autoimmune disease.